Economic Opportunity: Brand Drugs vs. Generic Drugs

Abstract

Outlines: * Pharmaceutical markets in the Middle East region are attractive *The high spending on branded drugs is unsustainable *Publicly funded health systems – increased pressure to reduce rising drug budgets *Originator (NDA) vs Generic (ANDA) review process requirements 20-90% cheaper generics * The generic drug industry is responsible for making more affordable and cost-saving medicines